Importantly, the risk score remained MI-503 chemical structure the significant prognostic risk factor (hazard ratio [HR] 1.36, 95% CI 1.13-1.64, P = 0.001 for OS) (Table 3). We next carried out ROC analysis to assess predictive performance of 3-year OS of 65-gene risk scores in a pooled test cohort and
compared it with other clinical variables that showed significance in univariate analysis (tumor size, vasculature invasion, grade, and AFP). The AUC of risk score (0.699; 95% CI, 0.636-0.764) is very close to that of tumor size (0.691; 95% CI, 0.628-0.755), the most significant clinical variable in univariate analysis (Fig. 3). Taken together, these findings suggest that the risk score retains its prognostic relevance even after the classical clinicopathological prognostic features have been taken into account. We further tested the independence of the risk score over current staging systems. Pexidartinib When the risk score was applied to patients with early stage (BCLC stage A) and intermediate and advanced stage (BCLC stage B and C) HCC, it successfully identified high-risk patients in different BCLC stages (Fig. 4). The risk score was also independent of American Joint Committee on Cancer (AJCC) stages (Supporting Fig. 3). We next tested whether a new risk score can improve the discrimination of prognosis over BCLC stages. Performance of the combined model (BCLC and risk score)
is substantially improved over the baseline models with only BCLC and risk score as evidenced by an increase of AUC from ROC analysis (Supporting Fig. 4A). Moreover, subset selleck products ROC analysis within each BCLC stage clearly demonstrated an incremental value of risk score over current staging system (Supporting Fig. 4B). Because vasculature invasion is the clinical variable best known to be significantly associated with
OS of HCC after surgical resection,27–31 we next tested how independent the new risk score is of vasculature invasion. As expected, the prognosis of patients without vasculature invasion was significantly better than that of patients with invasion (Supporting Fig. 5A). When the risk score-based stratification was applied separately to invasion-positive and -negative patients, it successfully identified high-risk patients in both subgroups (Supporting Fig. 5B,C). Importantly, when all stratifications were combined together the risk score even identified patients without vasculature invasion whose risk was worse than or similar to that of patients with invasion (Supporting Fig. 5D). We next examined the potential association of risk score with underlying liver disease by including Child-Pugh class and cirrhosis information into the analysis. As expected, Edmondson grade reflecting pathological characteristics of tumors showed an incremental association with risk score. The number of patients with a high risk score is slightly increased in higher grades.